Albumin-bilirubin score for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapy.
Shinya ShimizuYuichi HayashiShohei NishidaHironori FujiiMitsuhiro NakamuraNobuaki YoshikuraAkihito NaganoJunichi KitagawaNobuhiro KanemuraKosuke MizutaniRyo KobayashiTakuma IshiharaHideki HayashiTakayoshi ShimohataTadashi SugiyamaAkio SuzukiPublished in: Journal of clinical pharmacy and therapeutics (2021)
These findings indicate that ALBI score may be a useful biomarker for predicting neuropsychiatric symptoms in patients receiving ifosfamide-based chemotherapy.